Futura Medical plc (LON:FUM – Get Free Report)’s share price crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 9.95 ($0.13) and traded as low as GBX 9.32 ($0.13). Futura Medical shares last traded at GBX 10.20 ($0.14), with a volume of 47,992 shares traded.
Futura Medical Stock Performance
The firm has a market cap of £29.50 million, a P/E ratio of 2,367.80 and a beta of 1.25. The company has a 50-day moving average of GBX 10.26 and a 200 day moving average of GBX 9.95.
Futura Medical Company Profile
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel.
See Also
- Five stocks we like better than Futura Medical
- The 3 Best Fintech Stocks to Buy Now
- Is Qualcomm Tesla’s Next Rival in Autonomous Driving?
- Transportation Stocks Investing
- 3 Under-the-Radar Biotechs Under $5 That Could Soar 200%
- Best Aerospace Stocks Investing
- The Quiet Before the Catalyst: Vertical Aerospace’s Next Move
Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.
